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Summary 
Background High-volume prescribing of antibiotics in primary care is a major driver of antibiotic resistance. Education 
of physicians and patients can lower prescribing levels, but it frequently relies on highly trained staﬀ . We assessed 
whether internet-based training methods could alter prescribing practices in multiple health-care systems.
Methods After a baseline audit in October to December, 2010, primary-care practices in six European countries were 
cluster randomised to usual care, training in the use of a C-reactive protein (CRP) test at point of care, in enhanced 
communication skills, or in both CRP and enhanced communication. Patients were recruited from February to 
May, 2011. This trial is registered, number ISRCTN99871214.
Results The baseline audit, done in 259 practices, provided data for 6771 patients with lower-respiratory-tract infections 
(3742 [55·3%]) and upper-respiratory-tract infections (1416 [20·9%]), of whom 5355 (79·1%) were prescribed 
antibiotics. After randomisation, 246 practices were included and 4264 patients were recruited. The antibiotic 
prescribing rate was lower with CRP training than without (33% vs 48%, adjusted risk ratio 0·54, 95% CI 0·42–0·69) 
and with enhanced-communication training than without (36% vs 45%, 0·69, 0·54–0·87). The combined intervention 
was associated with the greatest reduction in prescribing rate (CRP risk ratio 0·53, 95% CI 0·36–0·74, p<0·0001; 
enhanced communication 0·68, 0·50–0·89, p=0·003; combined 0·38, 0·25–0·55, p<0·0001).
Interpretation Internet training achieved important reductions in antibiotic prescribing for respiratory-tract infections 
across language and cultural boundaries.
Funding European Commission Framework Programme 6, National Institute for Health Research, Research 
Foundation Flanders.
Introduction
Physicians prescribe antibiotics for many patients with 
acute uncomplicated lower-respiratory-tract infections, 
which are among the most common acute presentations 
in primary care.1–3 Most of these infections are viral, and 
evidence from systematic reviews4 and other studies5,6 
suggest only slight beneﬁ t is achieved from the pre-
scription of antibiotics. Thus, rationalisation of antibiotic 
use in the treatment of lower-respiratory-tract infections 
in primary care is a priority in the prevention of anti-
biotic resistance.7
C-reactive protein (CRP) has predictive value for 
pneumonia.8,9 In the IMPAC3T study,10 training of 
physicians in CRP testing lowered the rate of antibiotic 
prescribing by 20%. These ﬁ ndings were supported in a 
later study.11 The usefulness of training in consultation 
skills requires clariﬁ cation10 because there is limited 
evi dence for eﬀ ects on symptom control10,12,13 and 
whether a particular approach to training can be used 
in diﬀ erent settings.
Interactive workshops for health-care professionals 
and education of patients are likely to lower the rate of 
antibiotic prescribing.12,14,15 The IMPAC3T study10 showed 
that the training of physicians in advanced com-
munication skills by seminar role-playing and peer 
feedback on consultation transcripts reduced antibiotic 
prescribing rates by 20%. The STAR programme involves 
ﬁ ve stages of web-based training in advanced communi-
cation skills that include recording of reactions to 
scenarios, sharing of accounts of clinical experience, and 
expert-led face-to-face seminars. This approach led to 
a 4% reduction in global antibiotic use over 1 year in 
practices across Wales.16 Nevertheless, because such out-
reach interventions are generally performed by small 
groups of highly trained staﬀ  based at research centres of 
excellence, the generalisability of delivery and the poten-
tial eﬀ ects on real-world practice are questionable. Novel 
techniques are, therefore, needed to lead to changes at 
national and international levels. Internet training has 
the advantage that it can be disseminated widely at low 
cost and does not require highly trained outreach facili-
tators to be on site. In one study of internet training for 
general practitioners, the use of an interactive booklet 
for consultations with children attending for acute 
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respiratory-tract infections was eﬀ ective, but the sample 
and the setting had limitations, and no outcomes in 
patients were documented.13
The Genomics to combat Resistance against Antibiotics 
in Community-acquired LRTI in Europe (GRACE) 
consortium developed an internet-based training tool for 
lower-respiratory-tract infections that was found to be 
acceptable and applicable by physicians in several 
European countries.17 We report the eﬀ ects of training by 
this method on antibiotic prescribing and symptom 
control among adult patients.
Methods
Study design
This study was a multinational, cluster, randomised, 
factorial, controlled trial. We used a randomised cluster 
design to keep to a minimum contamination (inﬂ uence 
on participants’ behaviour when another participant or 
physician alters his or her behaviour) within practices, 
as more than one physician per practice could partici-
pate, and because a practice-based meeting was part of 
the intervention. The factorial design permitted assess-
ment of two training interventions—CRP testing and 
communication—in isolation and in combination. A 
baseline audit was undertaken in participating prac tices 
from October to December, 2010, to charac terise 
patients and the routine prescribing behaviour of phys-
icians. The interventions were pre dominantly aimed at 
patients with lower-respiratory-tract infections but were 
broadly based. Thus, we included patients with upper-
respiratory-tract infections to assess wider eﬀ ects of the 
interventions.
Ethics approval for the UK and Europe was granted 
by Southampton and South West Hampshire Local 
Research Ethics Committee. Research sites outside the 
UK also obtained ethics approval from their local 
organisations. Patients who fulﬁ lled the inclusion 
criteria were given written and verbal information 
about the study and were asked to provide written 
informed consent.
Practices
All general practices in the localities of study centres 
were approached and all clinicians (and nurse 
prescribers in the UK) in eligible practices who 
prescribed antibiotics for respiratory-tract infections 
were invited to participate. Eligible practices were those 
that had not previously used any interventions to reduce 
rates of antibiotic prescribing and could include more 
than ten patients in the baseline audit. Networks  of at 
least two practices were selected separately in Antwerp 
(Belgium), Barcelona (Spain), Cardiﬀ  (Wales), Łódź 
(Poland), Southampton (UK), Szczecin (Poland), 
Utrecht (Netherlands), and the Spanish Society of 
Family Medicine (Spain) to ensure a range of cultures, 
languages, and regions of Europe (north, south, and 
east) were represented. 
Patients
Up to the ﬁ rst 30 patients with lower-respiratory-tract 
infections and up to the ﬁ rst ﬁ ve with upper-respiratory-
tract infections who presented at each practice were 
recruited from February to May, 2011. Inclusion criteria 
were age older than 18 years; ﬁ rst consultation for acute 
cough of up to 28 days’ duration or what the clinician 
believed to be an acute lower-respiratory-tract infection as 
the main diagnosis, despite cough not being the most 
prominent symptom; and diagnosis judged by the 
physician to be an acute upper-respiratory-tract infection 
(eg, sore throat, otitis media, sinusitis, inﬂ uenza, and 
coryzal illness). Exclusion criteria were a working diagnosis 
of a non-infective disorder (eg, pulmonary embolus, heart 
failure, oesophageal reﬂ ux, or allergy); use of antibiotics in 
the previous month; inability to provide informed consent 
(eg, because of dementia, psychosis, or severe depression); 
pregnancy; and immunological deﬁ ciencies. Pneumonia 
was not an exclusion criterion.
Randomisation and masking
Randomisation of practices was done by KH and MK, 
was achieved by computer generation of random 
numbers, and was stratiﬁ ed by network. Minimisation 
was applied, on the basis of the proportion of patients 
prescribed antibiotics from the baseline audit, the 
number of participating physicians per practice, and the 
number of patients recruited. Practices were assigned to 
four trial arms: usual care; internet-based training to use 
a point-of-care CRP test; internet-based training in 
enhanced communication skills; or combined training in 
CRP testing and enhanced communication skills.
If only ten patients were recruited in a practice, the 
network average was used to avoid the unbalancing of 
randomisation by poorly estimated antibiotic pre scrib-
ing proportions for that practice. Physicians and 
patients were unaware of initial group allocation but 
masking of physicians or patients to the intervention 
itself was not possible.
Interventions
Randomisation was followed by a period of internet 
training and a repeat audit of antibiotic prescribing 
(February to May, 2011, the end of the season for 
respiratory-tract infections). The interventions were 
targeted at physicians rather than patients, and were 
developed iteratively to be sensitive to cultural and 
national diﬀ erences (appendix p 1).17 The usual-care 
group assessed and managed patients according to the 
practice’s normal procedures.
The CRP group received internet training on how to 
target testing (ie, in cases of clinical uncertainty, such as 
in patients with abnormal auscultation, dyspnoea, and 
fever18) and how to negotiate with the patient about 
management decisions (appendix p 2). Tests were done 
with QuikRead CRP kits (Orion Diagnostica, Espoo, 
Finland) after on-site training by the manufacturer. 
See Online for appendix
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During a run-in period of several weeks before data 
collection began, physicians practised using the device.
Training in enhanced communication skills focused on 
the gathering of information on patients’ concerns and 
expectations, exchange of information on symptoms, 
natural disease course, and treatments, agreement of a 
management plan, summing up, and providing guidance 
about when to reconsult. Physicians were also provided 
with an interactive booklet to use during consultations 
that included information on symptoms, use of antibiotics 
and antibiotic resistance, self-help measures, and when to 
re-consult (appendix p 3). The training was supported by 
video demonstrations of consultation techniques. The 
internet modules and materials were translated into the 
relevant national language and mainly addressed lower-
respiratory-tract infections, although many of the issues 
were relevant to all respiratory-tract infections.
Group practices were asked to appoint a lead physician 
to organise a structured meeting on prescribing issues. A 
survey was sent to all physicians after the study about 
approach to training (eg, completed alone or in a group) 
and the format of any group meetings (eg, within the 
practice or across multiple practices).
Case-report forms
During the index consultation physicians documented 
the duration of illness, severity of cough and other 
symptoms (rated 0, not problematic, to 4, severely 
problematic), severity of illness (assigned by physicians; 0, 
well to 10, very unwell), and use of antibiotics and tests 
on case-report forms created speciﬁ cally for the study, 
and data were uploaded centrally by network facilitators. 
After randomisation a more detailed case-report form 
was used in follow-up consultations that included the 
same details as the index form plus medical history, 
current medications, smoking status, ﬁ ndings of 
structured examination, whether CRP was tested, and 
whether the booklet was used.6 The study did not include 
an independent data safety monitoring board because it 
was deemed to be low risk. This approach is in line with 
that seen in low-risk trials that have been funded by the 
Medical Research Council.
Statistical analysis
The primary outcome was antibiotic use, as documented 
on the case-report forms. Limited availability of pre-
scription monitoring prevented the use of pharmacy 
dispensing data. Several secondary outcomes were 
assessed. New or worsening symptoms were deﬁ ned as 
re-consultation for new or worsening symptoms 
within 4 weeks, new signs, or hospital admission, 
assessed by review of medical notes (practice staﬀ , the 
local study team, or both used a standard form to report 
these data6). Symptom severity and duration was deﬁ ned 
as the severity of symptoms in the 2–4 days after seeing 
the physician.19 The duration of symptoms rated 
moderately bad or worse was also recorded.6 Symptoms 
were rated daily as 0 (no problem) to 6 (as bad as it could 
Figure: Trial proﬁ le
CRP=C-reactive protein.
440 practices approached
259 practices agreed to 
participate and enrolled
13 practices not randomised, 
recruited fewer than ten 
patients
Usual care 
(61 practices)
CRP training 
(62 practices)
Communication training 
(61 practices)
CRP and communication training 
(62 practices)
53 practices (870 patients) 
antibiotic prescription 
documented
58 practices (1062 patients) 
antibiotic prescription 
documented
55 practices (1170 patients) 
antibiotic prescription 
documented
62 practices (1162 patients) 
antibiotic prescription 
documented
Baseline data audit 
(259 practices, 6771 patients)
6 practices recruited 
no patients
4 practices recruited 
no patients
8 practices recruited 
no patients
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be) until they resolved and the information was reported 
by patients in self-completed diaries.20 For patients who 
did not return diaries, a short form that asked for details 
of duration and severity of symptoms and whether 
antibiotics or the booklet were used was sent by post for 
completion. If patients did not respond, researchers 
contacted them by telephone and asked the questions 
on the form.
To calculate the sample sizes we used α=0·025 (to 
allow for two interventions) and β=0·2, and assumed 
that up to 30 patients per practice would be recruited 
and that antibiotic prescribing would decrease by at 
least 10%, from 50% to 40%, in either one of the two 
intervention groups. We also assumed an intracluster 
coeﬃ  cient for antibiotic prescribing within practices of 
up to 0·16 (the mean of values in three previous 
studies10,21,22). We estimated that a sample of 940 (470 × 2) 
patients would be needed. Allowance for an inﬂ ation 
factor of 5·64 due to clustering, which was calculated as 
1 + ([30 – 1] × 0·16),  and rounding of numbers for the 
four subgroups gave an overall sample size of 5302. If a 
more usual intracluster coeﬃ  cient of up to 0·06 was 
assumed23 and controlled for patients’ and practices’ 
characteristics, a sample size of 2600 would be required. 
Thus we aimed to recruit a minimum of 2600 and a 
maximum of 5400 patients. The above assumptions 
were probably a conservative estimate of antibiotic 
reduction, on the basis of data from previous trials.10,13
Analyses were done by intention to treat and used 
multilevel logistic regression modelling for a factorial 
study to assess the main outcome (antibiotic use), 
controlled for baseline antibiotic prescribing rate and 
with allowance for clustering by physician and practice. 
The eﬀ ects of various potential confounders related to 
clinical severity (age, smoking, sex, major cardiovascular 
or respiratory comorbidity, baseline symptoms, crepi-
tations, wheeze, pulse higher than 100 beats per min, 
temperature higher 37·8°C, respiratory rate, blood 
pressure, physician’s rating of severity, and duration of 
cough) were explored because of the potential for 
selection bias in an open trial. If interactions between 
interventions were not signiﬁ cant, the results are 
presented as the main eﬀ ects of each intervention 
(ie, factorial groups with estimates controlling mutually 
for each intervention). A secondary analysis was done for 
individual groups because the study was not speciﬁ cally 
powered for interactions. The modelled odds ratios were 
converted to risk ratios according to the method described 
by Zhang and colleagues.24 We did no interim analyses. 
This trial is registered, number ISRCTN99871214.
Role of the funding source
The sponsor of the study had no role in study design, 
data collection, data analysis, data interpretation, or 
writing of the report. The corresponding author had full 
access to all the data in the study and had ﬁ nal 
responsibility for the decision to submit for publication. 
Results
Of 446 practices approached, 259 agreed to participate 
(ﬁ gure). They contributed baseline data for 6771 patients 
(5355 [79·1%] with lower-respiratory-tract infections 
and 1416 [20·9%] with upper-respiratory-tract infec-
tions), of whom 3742 (55·3%) were prescribed anti-
biotics. 13 practices included fewer than ten patients in 
the baseline audit and did not progress to 
 Baseline 
(n=6771)
No CRP training
(n=2040)
CRP training
(n=2224)
No communication training 
(n=1932)
Communication training 
(n=2332)
Gender (male/
female)
2553 (38%)/4218 (62%) 729 (36%)/1311 (64%) 801 (36%)/1423 (64%) 709 (37%)/1223 (63%) 821 (35%)/1511 (65%)
Age (years) 49·6 (18·6) 50·9 (17·3) 51·0 (17·5) 50·8 (17·6) 51·1 (17·2)
Non-smoker (past or 
current)
N/A 1067 (52%) 1147 (52%) 1041 (54%) 1173 (50%)
Illness duration 
before index 
consultation (days)
7·8 (7·2) 7·6 (6·0) 7·8 (7·1) 8·0 (7·1) 7·5 (6·2)
Respiratory rate 
(breaths per min)
N/A 17·0 (5·3) 17·0 (5·7) 17·3 (5·7) 16·8 (5·2)
Temperature (ºC) N/A 36·7 (0·9) 36·8 (0·9) 36·7 (0·8) 36·8 (0·9)
Lung disease (COPD 
or asthma)
N/A 341/1992 (17%) 422/2195 (19%) 333/1881 (18%) 430/2306 (19%)
Severity score (all 
symptoms)*
1·8 (0·5) 1·9 (0·5) 2·0 (0·5) 2·0 (0·6) 1·9 (0·5)
Severity of cough* 3·0 (0·8) 3·1 (0·8) 3·1 (0·8) 3·0 (0·9) 3·1 (0·8)
Sputum production 5355/6771 (79%) 1628/1996 (82%) 1830/2263 (81%) 1572/1967 (80%) 1886/2292 (82%)
Data are number (%) or mean (SD). CRP=C-reactive protein. COPD=chronic obstructive pulmonary disease. *Severity of symptoms rated as 1=no problem, 2=mild problem, 
3=moderate problem, and 4=severe problem.
Table 1: Clinical characteristics of factorial groups at baseline and during follow-up 
Articles
www.thelancet.com   Vol 382   October 5, 2013 1179
randomisation. 372 participating physicians in 228 (92·7%) 
of 246 randomised practices contributed 4264 patients at 
follow-up (ﬁ gure) of whom 3398 (79·7%) of 4264 had 
lower-respiratory-tract infections and the remainder had 
other respiratory-tract infections.
All groups were well balanced (table 1). Adherence 
to training was good in all intervention groups, 
with 99 (87·6%) 113 of practices completing the CRP 
training and 94 (87·0%) of 108 completing the com-
munication training (appendix p 4).
All the modelled results allowed for clustering by 
practice but not network, as little variance was seen due 
to networks (appendix p 4). In the usual-care group 508 
(58·4%) of 870 patients were prescribed antibiotics, 
which was similar to the rate at baseline. Analysis of the 
factorial groups showed that in the CRP group antibiotic 
prescribing was reduced by 15% compared with usual 
care and in the enhanced communication group it was 
reduced by 9% (table 2). In patients managed by phys-
icians who had received CRP training, the median time 
to resolution of symptoms rated as moderately bad or 
worse was the same as that in the usual-care group 
(5 days), whereas in those treated by physicians in the 
enhanced-communication group the time was 6 days 
(table 3). For both interventions symptom severities in 
the 2–4 days after seeing the doctor were similar to those 
in the usual-care group, and the rates of new or worsening 
symptoms did not diﬀ er signiﬁ cantly (table 3). In a full 
model with all potential confounders, the interaction 
term between CRP and enhanced-communication train-
ing for the primary outcome was 1·33 and was not 
signiﬁ cant (p=0·414). In the individual group results for 
clinical characteristics and outcomes (appendix pp 5–6) 
antibiotic prescribing was decreased the most in the 
combination intervention group compared with usual 
care (CRP group risk ratios 0·53, 95% CI 0·36–0·74, 
p<0·0001; communi cation group 0·68, 0·50–0·89, 
p=0·003; combined group 0·38, 0·25–0·55, p<0·0001). 
For lower-respiratory-tract infections versus upper-
respiratory-tract infections, results were similar to those 
for the whole cohort, but in the enhanced-communication 
group, symptom control for upper-respiratory-tract infec-
tions was possibly a little less eﬀ ective than that for 
lower-respiratory-tract infections (appendix pp 7–10).
30 patients were reported as being admitted to hospital 
(two in the usual-care group, ten in the CRP group, six 
in the enhanced-communication group, and 12 in the 
combined group). The reasons (noted in 15 patients) 
were mostly cardiorespiratory problems or systemic 
upset (cardiac n=2; respiratory n=8; generally unwell or 
pyrexial n=2; gastrointestinal symptoms n=2; sinusitis 
n=1). The diﬀ erence in hospital-admission rates between 
the CRP group and the non-CRP group (22 vs eight) 
was signiﬁ cant when controlled for clustering (odds 
ratio 2·61, 95% CI 1·07–6·35, p=0·034), but of borderline 
signiﬁ cance when controlled for all potential confounders 
(2·91, 0·96–8·85, p=0·060). No patients died.
Discussion
This study of the eﬀ ectiveness of internet training to 
modify antibiotic prescribing for respiratory-tract infec-
tions followed a period of careful intervention develop-
ment across major language, cultural, and health-system 
boundaries. Our ﬁ ndings suggest that these inter-
ventions are transferable between very diﬀ erent 
primary-care settings.
The practices involved in the study had previously 
shown no interest in their levels of antibiotic prescribing 
and many were research naive. The prescribing rate at 
baseline (55·3%) was similar to that in a previous 
observational study,5 where most patients were given 
antibiotics. Although recruitment was not complex, 
some practices did not include the minimum number 
No CRP training CRP training No communication 
training
Communication 
training
Crude percentage 48% (984/2040) 33% (734/2224) 45% (876/1932) 36% (842/2332)
Basic risk ratio 
(95% CI)*
1·00 0·58 (0·48–0·70, 
p<0·0001 )
1·00 0·76 (0·63–0·89, 
p<0·0001)
Adjusted risk ratio† 1·00 0·54 (0·42–0·69, 
p<0·0001)
1·00 0·69 (0·54–0·87, 
p<0·0001)
CRP=C-reactive protein. *The basic model adjusted for baseline prescribing and clustering by physician and practice. 
†The adjusted model additionally controlled for age, smoking, sex, major cardiovascular or respiratory comorbidity, 
baseline symptoms, crepitations, wheeze, pulse higher than 100 beats per min, temperature higher than 37·8°C, 
respiratory rate, blood pressure, physician’s rating of severity, and duration of cough. 
Table 2: Eﬀ ectiveness of CRP and enhanced-communication training in reducing antibiotic prescribing rates 
No CRP training CRP training No communication 
training 
Communication 
training
New or worse symptoms
Crude percentage 
of  patients (%)
18% (361/1962) 19% (399/2159) 16% (309/1879) 20% (451/2242)
Basic risk ratio* 1·00 1·06 (0·80 to 1·40, 
p=0·67)
1·00 1·27 (0·96 to 1·67, 
p=0·10)
Adjusted risk ratio† 1·00 1·05 (0·78 to 1·39, 
p=0·76)
1·00 1·33 (0·99 to 1·74, 
p=0·055)
Symptom severity score days 2–4 after index consultation
Crude mean (SD) 
score
1·79 (0·99) 1·79 (1·01) 1·73 (0·98) 1·84 (1·02)
Basic mean 
diﬀ erence* 
·· –0·01 (–0·11 to 0·10, 
p=0·85)
.. 0·09 (–0·02 to 0·20, 
p=0·10)
Adjusted mean 
diﬀ erence† 
·· 0 (–0·09 to 0·09, 
p=0·99)
.. 0·07 (–0·03 to 0·16, 
p=0·16)
Resolution of symptoms rated moderately bad or worse
Crude median (IQR) 
time (days)
5 (3 to 9) 5 (3 to 9) 5 (3 to 7) 6 (3 to 10)
Basic hazard ratio* 1·00 0·99 (0·89 to 1·12, 
p=0·91)
1·00 0·87 (0·77 to 0·97, 
p=0·015)
Adjusted hazard 
ratio†
1·00 0·93 (0·83 to 1·04, 
p=0·21)
1·00 0·83 (0·74 to 0·93, 
p=0·002)
CRP=C-reactive protein. *The basic model adjusted for baseline prescribing and clustering by physician and practice. 
†The adjusted model additionally controlled for age, smoking, sex, major cardiovascular or respiratory comorbidity, 
baseline symptoms, crepitations, wheeze, pulse higher than 100 beats per min, temperature higher than 37·8°C, 
respiratory rate, blood pressure, physician’s rating of severity, and duration of cough.
Table 3: Eﬀ ectiveness of CRP training and enhanced-communication training on symptom control 
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of patients in the baseline audit, which supports the 
everyday nature of those practices. The baseline 
prescribing rate in the usual-care group was similar to 
those in the other groups, which suggests minimum 
attrition bias. Control for patients’ characteristics only 
slightly altered estimated prescribing rates and 
remained similar in all intervention groups, which 
indicates minimum confounding. The limited change 
in prescribing rate in the usual-care group, and the 
slightly worse symptomatic outcomes in the intervention 
groups, which were in line with evidence from placebo-
controlled trials,4,6 suggest that the reductions in 
antibiotic prescribing in intervention groups were 
genuine. We assessed adherence to training but did not 
observe consultations to avoid introducing bias to 
clinicians’ behaviour. The long-term eﬀ ects of our study 
interventions on behaviour are unknown, although 
similar interventions have had lasting eﬀ ects.10,16,25
The eﬃ  cacy of the multifactorial enhanced-communi-
cation intervention supports evidence that interactive 
methods, rather than simply providing educational 
information, are most eﬀ ective.12,14 In the STAR trial,16 
a 4% reduction in global antibiotic use was noted, but 
that trial was much more intensive than ours (ﬁ ve online 
training phases vs one in this study, plus expert-led 
outreach seminars). Our intervention caused slightly less 
reduction in prescribing rates than that used in the 
IMPAC3T study. The risk ratio for antibiotic prescribing 
was 0·49 for communication training in IMPAC3T, 
compared with 0·68 in our study,10 but that intervention 
was also more intensive than ours (outreach visits plus 
peer review of consultations). Despite our  interventions 
predominantly addressing lower-respiratory-tract infec-
tions, prescribing rates fell for upper-respiratory-tract 
infections, which suggests further modiﬁ cations of the 
booklet and training to better address upper-respiratory-
tract infections could improve eﬃ  cacy. Although the 
diagnostic value of CRP testing has been questioned in 
systematic reviews,8,26 our ﬁ ndings are similar to those 
in intensive Dutch trials10,11 and suggest that internet-
based training on CRP testing promotes non-antibiotic 
manage ment strategies when the ﬁ ndings of qualitative 
work support the quantitative ﬁ ndings.17 In view of the 
additional resources needed for CRP testing (training, 
equipment, and time for testing and discussion of 
results) the cost-eﬀ ectiveness of this intervention 
remains to be shown.
No intervention aﬀ ected symptom severity in the ﬁ rst 
few days, but the median time to resolution of moderately 
severe or worse symptoms was slightly longer in the 
enhanced-communication group than in the usual-care 
group (by 1 day). The risk of new or worsening symptoms 
was also raised in the combined group (appendix pp 6−7), 
which lessens the likelihood that training in CRP training 
protects against symptom progression. These ﬁ ndings 
might have been due to the 12% rate of symptom 
reporting in the usual-care group. However, this rate is 
lower than that in the placebo group of a previous large 
trial6 and requires conﬁ rmation. Symptom control might 
be worse in patients with upper-respiratory-tract infec-
tions than in those with lower-respiratory-tract infections, 
but this ﬁ nding should be interpreted cautiously as it was 
a secondary outcome and the interaction term was not 
signiﬁ cant. The IMPAC3T trial10 provided little evidence 
of poor symptom control, although the duration of severe 
symptoms and the rates of new or worsening symptoms 
were not reported. Symptom control was also not 
Panel: Research in context
Arnold and Straus12 searched the Cochrane Eﬀ ective Practice and Organisation of Care 
Group (EPOC) specialised register (supplemented by the bibliographies of studies found in 
the register and the Science Citation Index), and identiﬁ ed 39 randomised studies and 
quasirandomised studies. They found that multifaceted interventions were most successful 
in reducing the rate of antibiotic prescribing. We searched Medline, Embase, and The 
Cochrane Library for articles published from January, 1990, to July, 2009, with several 
combinations of the following keywords: “antibiotic”, “primary care”, “intervention”, 
“respiratory tract infection”, and speciﬁ c MeSH terms for respiratory-tract-infection 
diagnoses. We manually screened reference lists to identify further articles of interest. 
Inclusion criteria for articles were an intervention primarily targeted at physicians in a 
primary care setting aiming to improve antibiotic prescription for respiratory-tract 
infections, studies done in high-income countries, presentation of a standardised outcome 
of ﬁ rst-choice prescription measured in deﬁ ned daily dosage, prescriptions or rates, and 
publication in the English language. Relevance of studies was screened by assessments of 
titles, keywords, abstracts, and full texts, independently by two reviewers. Disagreements 
were resolved by consensus or arbitration by a third person. The main reasons for exclusion 
were a lack of standardised outcomes or a clear description of intervention features. We 
identiﬁ ed 58 studies describing 87 interventions in primary care related to antibiotic 
prescribing for respiratory-tract infections, and conﬁ rmed that multiple interventions 
containing at least educational material for physicians were most frequently eﬀ ective. 
This ﬁ nding underscored promising evidence for communication-skills training and 
near-patient testing.15 Patients’ outcomes, however, were rarely reported, the participants 
and settings were generally restricted, and outreach interventions used highly trained staﬀ  
at research centres of excellence and, therefore, the generalisability of interventions seemed 
poor. Only one trial had used the internet for intervention delivery. In a study that involved 
246 primary-care practices in six European countries with diﬀ erent languages, cultures, and 
health systems, we aimed to assess the eﬀ ect of internet-based training in the use of a 
C-reactive protein point-of-care test and in enhanced communication skills, supported by  
an interactive booklet for patients. 
Interpretation 
Both types of training were associated with notable reductions in antibiotic prescribing 
rates, but the two training methods combined had the greatest eﬀ ect (C-reactive-protein 
intervention risk ratio 0·53, 95% CI 0·36–0·74; enhanced-communication intervention 
0·68, 0·50–0·89; combined intervention 0·38, 0·25–0·55). We found evidence of slightly 
lengthened duration (1 day) of symptoms rated moderately bad or worse with the 
enhanced-communication training, and increased hospital admissions with C-reactive-
protein training (22 vs eight with usual care), but these outcomes may be balanced against 
the potential beneﬁ ts (reduced antibiotic prescribing, demedicalisation of self-limiting 
illness,6,19 reduced risk of antibiotic-associated side-eﬀ ects, and reduced risk of antibiotic 
resistance). The easily accessible format of internet-based intervention delivery and the 
success of the interventions across national language and cultural boundaries suggest that 
these interventions could be implemented widely in many health systems.
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reported in a previous trial of internet-based communi-
cation training with an accompanying booklet.13 The 
perception of worse symptoms could have been due to 
expectations about the eﬀ ectiveness of antibiotics in an 
open trial, although similar open trials have not reported 
such eﬀ ects.10,27,28 The use of the interactive booklet might 
have led to increased re-consultation rates by emphasis 
of the long natural history of respiratory-tract infections 
and the raising of awareness of symptoms for which re-
consultation is recommended. Likewise, although an 
increased rate of hospital admission could have indicated 
a negative eﬀ ect with the CRP intervention, it might have 
reﬂ ected appropriate management. The slightly worse 
symptom control in the enhanced-communication group 
high lights the paucity of high-quality evidence for 
eﬀ ective treatments.29 Improved symptom control should 
become a research priority. The risk of potential 
intervention-related harm (possibility of worse symptom 
control or increased rate of hospital admissions) must be 
balanced by the potential beneﬁ ts (reduced antibiotic 
prescribing, demedicalisation of self-limiting illness,6,19 
reduced risk of antibiotic-associated side-eﬀ ects, and 
reduced risk of antibiotic resistance; panel).
Internet-based training in how to use a CRP point-of-
care test or in enhanced communication skills plus use 
of an interactive information booklet achieved important 
reductions in antibiotic prescribing for respiratory-tract 
infections in several countries. These interventions, 
therefore, can be disseminated widely and maintain 
eﬃ  cacy. Eﬀ ective symptom-control strategies are needed 
to support reductions in antibiotic prescribing.
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